Anbio Biotechnology Class A(NNNN)
$3.80-0.25 (-6.17%)
NNNN
Anbio Biotechnology Class A financials statements
$3.80
At close:-0.25 (-6.17%)
Anbio Biotechnology Class A (NNNN) Income Statement
62 Followers
Anbio Biotechnology Class A Income Statement
Last quarter (Q4 2025), Anbio Biotechnology Class A's total revenue was $4.74M, an increase of 87.39% from the same quarter last year. In Q4, Anbio Biotechnology Class A's net income was $3.04M. See Anbio Biotechnology Class A’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 8.65M | $ 8.19M | $ 6.71M | $ 23.54M | $ 4.43M | |
| $ 7.54M | $ 5.89M | $ 3.36M | $ 12.56M | $ 2.54M | |
| $ 1.78M | $ 3.89M | $ 1.40M | $ 2.37M | $ 86.09K | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 12.06K | $ 6.25K | $ 0.00 |
| $ 5.77M | $ 2.00M | $ 2.27M | $ 10.03M | $ 2.54M | |
| $ 5.77M | $ 2.00M | $ 1.96M | $ 10.20M | $ 2.46M | |
| $ 635.72K | $ 377.48K | $ 292.78K | $ -184.41K | $ 79.94K | |
| $ 6.40M | $ 2.37M | $ 2.25M | $ 10.01M | $ 2.54M | |
| $ 6.40M | $ 2.37M | $ 2.25M | $ 10.01M | $ 2.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.16 | $ 0.06 | $ 0.02 | $ 0.07 | $ 0.03 |
| Diluted EPS | $ 0.16 | $ 0.06 | $ 0.01 | $ 0.07 | $ 0.03 |
| Weighted Average Shares Outstanding | 43.89M | 42.29M | 143.89M | 143.89M | 100.00M |
| Weighted Average Shares Outstanding (Diluted) | 43.89M | 42.29M | 187.78M | 143.89M | 100.00M |
Currency in USD
